These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 11014378)

  • 1. A subtherapeutic international normalized ratio despite increasing doses of warfarin: could this be malabsorption?
    Lara LF; Delgado LL; Frazee LA; Haupt KM; Rutecki GW
    Am J Med Sci; 2000 Sep; 320(3):214-8. PubMed ID: 11014378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malabsorption-associated warfarin resistance.
    Sabol BJ; Basa RR; Wilkins CE
    Am J Health Syst Pharm; 2009 Sep; 66(17):1548-53. PubMed ID: 19710438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Warfarin resistance in a patient with short bowel syndrome.
    Brophy DF; Ford SL; Crouch MA
    Pharmacotherapy; 1998; 18(3):646-9. PubMed ID: 9620117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous warfarin as an alternative for anticoagulation.
    Gellatly RM
    Pharmacotherapy; 2007 Jun; 27(6):933-5. PubMed ID: 17542775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral anticoagulants and cyclosporin A.
    Turri D; Iannitto E; Caracciolo C; Mariani G
    Haematologica; 2000 Aug; 85(8):893-4. PubMed ID: 10942954
    [No Abstract]   [Full Text] [Related]  

  • 6. Bioavailability of warfarin in a patient with severe short bowel syndrome.
    Kearns PJ; O'Reilly RA
    JPEN J Parenter Enteral Nutr; 1986; 10(1):100-1. PubMed ID: 3945042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Warfarin therapy: evolving strategies in anticoagulation.
    Horton JD; Bushwick BM
    Am Fam Physician; 1999 Feb; 59(3):635-46. PubMed ID: 10029789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An algorithm for managing warfarin resistance.
    Osinbowale O; Al Malki M; Schade A; Bartholomew JR
    Cleve Clin J Med; 2009 Dec; 76(12):724-30. PubMed ID: 19952297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significant pharmacokinetic and pharmacodynamic interaction of warfarin with the NO-independent sGC activator HMR1766.
    Oberwittler H; Hirschfeld-Warneken A; Wesch R; Willerich H; Teichert L; Lehr KH; Ding R; Haefeli WE; Mikus G
    J Clin Pharmacol; 2007 Jan; 47(1):70-7. PubMed ID: 17192504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overview of pharmacogenetics in anticoagulation therapy.
    Hill CE; Duncan A
    Clin Lab Med; 2008 Dec; 28(4):513-24. PubMed ID: 19059059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance to oral vitamin K for reversal of overanticoagulation during Crohn's disease relapse.
    Fugate SE; Ramsey AM
    J Thromb Thrombolysis; 2004 Jun; 17(3):219-23. PubMed ID: 15353921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and pharmacodynamics of tecarfarin, a novel vitamin K antagonist oral anticoagulant.
    Albrecht D; Ellis D; Canafax DM; Combs D; Druzgala P; Milner PG; Midei MG
    Thromb Haemost; 2017 Apr; 117(4):706-717. PubMed ID: 28180234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of torsemide on pharmacodynamics and pharmacokinetics of warfarin in humans and rats.
    Kim HO; Lee KE; Park HY; Lee NR; Oh BR; Chang BC; Gwak HS
    J Pharm Pharmacol; 2013 Aug; 65(8):1195-203. PubMed ID: 23837587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Warfarin resistance.
    Sinxadi P; Blockman M
    Cardiovasc J Afr; 2008; 19(4):215-7. PubMed ID: 18776969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic testing to guide warfarin dosing: Impact of direct oral anticoagulants.
    Lentz SR
    Clin Pharmacol Ther; 2016 Aug; 100(2):128-30. PubMed ID: 27178490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gender differences in pharmacokinetics of oral warfarin in rats.
    Zhu X; Shin WG
    Biopharm Drug Dispos; 2005 May; 26(4):147-50. PubMed ID: 15776499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Warfarin resistance due to malabsorption.
    Talstad I; Gamst ON
    J Intern Med; 1994 Oct; 236(4):465-7. PubMed ID: 7931050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient factors that influence warfarin dose response.
    White PJ
    J Pharm Pract; 2010 Jun; 23(3):194-204. PubMed ID: 21507814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of microdosing to predict pharmacokinetics at the therapeutic dose: experience with 5 drugs.
    Lappin G; Kuhnz W; Jochemsen R; Kneer J; Chaudhary A; Oosterhuis B; Drijfhout WJ; Rowland M; Garner RC
    Clin Pharmacol Ther; 2006 Sep; 80(3):203-15. PubMed ID: 16952487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and comparison of a warfarin-dosing algorithm for Korean patients with atrial fibrillation.
    Cho HJ; On YK; Bang OY; Kim JW; Huh W; Ko JW; Kim JS; Lee SY
    Clin Ther; 2011 Oct; 33(10):1371-80. PubMed ID: 21981797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.